Description

Lanadelumab is a monoclonal antibody used in the treatment of hereditary angioedema, a genetic condition that causes recurrent episodes of severe swelling. It works by inhibiting the activity of plasma kallikrein, an enzyme involved in the inflammatory process.

Interpreter Notes

Interpreters should be aware that Lanadelumab may be referred to by its brand name in some contexts. It is important to maintain a formal register when discussing this medication, as it is used in clinical settings. Avoid colloquial terms that may confuse patients or healthcare professionals.

Example Sentences

EN: The patient was prescribed Lanadelumab to manage his hereditary angioedema episodes.

ES: Al paciente se le recetó Lanadelumab para manejar sus episodios de angioedema hereditario.

Common Interpreter Mistakes

Confusing Lanadelumab with other medications for angioedema; using informal language when discussing a clinical medication; mispronouncing the drug name leading to misunderstandings.